Cargando…
Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality
OBJECTIVES: To investigate the rates and causality of adverse event(s) (AE) associated with natural health product (NHP) use, prescription drug use and concurrent NHP-drug use through active surveillance in community pharmacies. DESIGN: Cross-sectional study of screened patients. SETTING: 10 communi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975764/ https://www.ncbi.nlm.nih.gov/pubmed/24682573 http://dx.doi.org/10.1136/bmjopen-2013-003431 |
_version_ | 1782310190190690304 |
---|---|
author | Necyk, Candace Tsuyuki, Ross T Boon, Heather Foster, Brian C LeGatt, Don Cembrowski, George Murty, Mano Barnes, Joanne Charrois, Theresa L Arnason, John T Ware, Mark A Rosychuk, Rhonda J Vohra, Sunita |
author_facet | Necyk, Candace Tsuyuki, Ross T Boon, Heather Foster, Brian C LeGatt, Don Cembrowski, George Murty, Mano Barnes, Joanne Charrois, Theresa L Arnason, John T Ware, Mark A Rosychuk, Rhonda J Vohra, Sunita |
author_sort | Necyk, Candace |
collection | PubMed |
description | OBJECTIVES: To investigate the rates and causality of adverse event(s) (AE) associated with natural health product (NHP) use, prescription drug use and concurrent NHP-drug use through active surveillance in community pharmacies. DESIGN: Cross-sectional study of screened patients. SETTING: 10 community pharmacies across Alberta and British Columbia, Canada from 14 January to 30 July 2011. PARTICIPANTS: The participating pharmacy staff screened consecutive patients, or agents of patients, who were dropping or picking up prescription medications. PRIMARY OUTCOME MEASURES: Patients were screened to determine the proportions of them using prescription drugs and/or NHPs, as well as their respective AE rates. All AEs reported by the screened patients who took a NHP, consented to, and were available for, a detailed telephone interview (14%) were adjudicated fully to assess for causality. RESULTS: Over a total of 105 pharmacy weeks and 1118 patients screened, 410 patients reported taking prescription drugs only (36.7%; 95% CI 33.9% to 39.5%), 37 reported taking NHPs only (3.3%; 95% CI 2.4% to 4.5%) and 657 reported taking prescription drugs and NHPs concurrently (58.8%; 95% CI 55.9% to 61.6%). In total, 54 patients reported an AE, representing 1.2% (95% CI 0.51% to 2.9%), 2.7% (95% CI 0.4% to 16.9%) and 7.3% (95% CI 5.6% to 9.6%) of each population, respectively. Compared with patients who reported using prescription drugs, the patients who reported using prescription drugs and NHPs concurrently were 6.4 times more likely to experience an AE (OR; 95% CI 2.52 to 16.17; p<0.001). Combined with data from Ontario, Canada, a national proportion was calculated, which found that 45.4% (95% CI 43.8% to 47.0%) of Canadians who visit community pharmacies take NHPs and prescription drugs concurrently, and of those, 7.4% (95% CI 6.3% to 8.8%) report an AE. CONCLUSIONS: A substantial proportion of community pharmacy patients use prescription drugs and NHPs concurrently; these patients are at a greater risk of experiencing an AE. Active surveillance provides a means of detecting such AEs and collecting high-quality data on which causality assessment can be based. |
format | Online Article Text |
id | pubmed-3975764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39757642014-04-07 Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality Necyk, Candace Tsuyuki, Ross T Boon, Heather Foster, Brian C LeGatt, Don Cembrowski, George Murty, Mano Barnes, Joanne Charrois, Theresa L Arnason, John T Ware, Mark A Rosychuk, Rhonda J Vohra, Sunita BMJ Open Complementary Medicine OBJECTIVES: To investigate the rates and causality of adverse event(s) (AE) associated with natural health product (NHP) use, prescription drug use and concurrent NHP-drug use through active surveillance in community pharmacies. DESIGN: Cross-sectional study of screened patients. SETTING: 10 community pharmacies across Alberta and British Columbia, Canada from 14 January to 30 July 2011. PARTICIPANTS: The participating pharmacy staff screened consecutive patients, or agents of patients, who were dropping or picking up prescription medications. PRIMARY OUTCOME MEASURES: Patients were screened to determine the proportions of them using prescription drugs and/or NHPs, as well as their respective AE rates. All AEs reported by the screened patients who took a NHP, consented to, and were available for, a detailed telephone interview (14%) were adjudicated fully to assess for causality. RESULTS: Over a total of 105 pharmacy weeks and 1118 patients screened, 410 patients reported taking prescription drugs only (36.7%; 95% CI 33.9% to 39.5%), 37 reported taking NHPs only (3.3%; 95% CI 2.4% to 4.5%) and 657 reported taking prescription drugs and NHPs concurrently (58.8%; 95% CI 55.9% to 61.6%). In total, 54 patients reported an AE, representing 1.2% (95% CI 0.51% to 2.9%), 2.7% (95% CI 0.4% to 16.9%) and 7.3% (95% CI 5.6% to 9.6%) of each population, respectively. Compared with patients who reported using prescription drugs, the patients who reported using prescription drugs and NHPs concurrently were 6.4 times more likely to experience an AE (OR; 95% CI 2.52 to 16.17; p<0.001). Combined with data from Ontario, Canada, a national proportion was calculated, which found that 45.4% (95% CI 43.8% to 47.0%) of Canadians who visit community pharmacies take NHPs and prescription drugs concurrently, and of those, 7.4% (95% CI 6.3% to 8.8%) report an AE. CONCLUSIONS: A substantial proportion of community pharmacy patients use prescription drugs and NHPs concurrently; these patients are at a greater risk of experiencing an AE. Active surveillance provides a means of detecting such AEs and collecting high-quality data on which causality assessment can be based. BMJ Publishing Group 2014-03-28 /pmc/articles/PMC3975764/ /pubmed/24682573 http://dx.doi.org/10.1136/bmjopen-2013-003431 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Complementary Medicine Necyk, Candace Tsuyuki, Ross T Boon, Heather Foster, Brian C LeGatt, Don Cembrowski, George Murty, Mano Barnes, Joanne Charrois, Theresa L Arnason, John T Ware, Mark A Rosychuk, Rhonda J Vohra, Sunita Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title | Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title_full | Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title_fullStr | Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title_full_unstemmed | Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title_short | Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
title_sort | pharmacy study of natural health product adverse reactions (sonar): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality |
topic | Complementary Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975764/ https://www.ncbi.nlm.nih.gov/pubmed/24682573 http://dx.doi.org/10.1136/bmjopen-2013-003431 |
work_keys_str_mv | AT necykcandace pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT tsuyukirosst pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT boonheather pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT fosterbrianc pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT legattdon pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT cembrowskigeorge pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT murtymano pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT barnesjoanne pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT charroistheresal pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT arnasonjohnt pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT waremarka pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT rosychukrhondaj pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality AT vohrasunita pharmacystudyofnaturalhealthproductadversereactionssonaracrosssectionalstudyusingactivesurveillanceincommunitypharmaciestodetectadverseeventsassociatedwithnaturalhealthproductsandassesscausality |